Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of inflammatory cytokine changes in total laparoscopic hysterectomy vs myomectomy under TIVA with propofol and remimazolam
KCT0007611Phase 4Recruiting
- Sponsor
- Hana Pharm
- Start
- Oct 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of propofol, remimazolam in Fibromyoma (LM), sponsored by Hana Pharm. Started Oct 2021; status: recruiting.
02
Drugs
propofolremimazolam
03
Conditions
Fibromyoma (LM)
Beyond the preview
Go deeper on KCT0007611.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0007611.